Section Arrow
CADL.NASDAQ
- Candel Therapeutics
Quotes are at least 15-min delayed:2026/04/05 17:51 EDT
Regular Hours
Last
 5
+0.02 (+0.40%)
Day High 
5.105 
Prev. Close
4.98 
1-M High
5.295 
Volume 
910.35K 
Bid
4.81
Ask
4.94
Day Low
4.84 
Open
4.85 
1-M Low
4.44 
Market Cap 
364.77M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 4.87 
20-SMA 4.94 
50-SMA 5.34 
52-W High 7.25 
52-W Low 4.25 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.72/-0.47
Enterprise Value
413.36M
Balance Sheet
Book Value Per Share
0.71
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.00
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
COCPCocrystal Pharma1.51+0.49+48.04%-- 
BDRXBiodexa Pharmaceuticals plc0.8733+0.2593+42.23%-- 
IOBTIO Biotech0.0323-0.0114-26.09%-- 
GERNGeron Corp1.66------ 
ELABPmgc Holdings Inc5.72-8.28-59.14%0PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.